Loading annual review details
Carpenter Technology Corporation (CRS)FY2026 investor yearly review
Across FY2026, management guided investors through a mid-year demand inflection that translated into accelerating order intake—especially in aerospace—while SAO margins kept trending higher quarter after quarter. Free cash flow improved as productivity and working-capital actions offset planned maintenance and ramping brownfield spending.
Overall investor read
Strong execution with demand and pricing credibility
Management’s narrative held together: sustained SAO margin expansion and escalating aerospace activity into Q4.
Primary financial signal
$362.3M free cash flow
Full-year cash generation rose while capex scaled for the brownfield project and buybacks continued through Q4.
Primary call signal
Aerospace build-rate ramp stayed central
Quarterly commentary increasingly emphasized booking acceleration and customer urgency as inventories tightened across the supply chain.
Headline metrics summarize FY2026 performance and cash generation.
Revenue
Revenue rose year over year on strengthening high-value demand.
Gross margin
Gross margin stayed elevated as productivity and pricing actions compounded.
Operating margin
Operating margin reflected operating leverage with SAO margin expansion.
Net income
Net income increased meaningfully, supported by higher profitability.
Diluted EPS
EPS growth tracked the profitability step-up through Q3 and Q4.
Free cash flow
Free cash flow remained strong and improved as working capital stayed controlled.
Net debt
Balance sheet leverage stayed manageable while growth capex and buybacks ran.
Current ratio
Liquidity remained robust, supporting capital allocation through the year.
FY2026 progressed from “record-but-uneven quarter” to “durable aerospace ramp” as management used SAO margin expansion, LTAs/pricing, and supply-tightness urgency to tie results to a strengthening demand environment.
Aerospace demand
Across Q1 to Q4, management repeatedly tied bookings acceleration to OEM build-rate progress and inventory tightening across the aerospace supply chain. Q2 highlighted structural customers moving off sidelines; Q3 and Q4 added urgency via expedite requests and customers asking for earlier material.
Quarter-by-quarter materiality and tone for annual transcript themes.
Scroll horizontally to see more columns.
| Theme | Q1 | Q2 | Q3 | Q4 | Next monitor |
|---|---|---|---|---|---|
| Aerospace build-rate ramp shifts from steady ordering to urgency | Positive Aerospace bookings accelerated sequentially; management linked demand to OEM build confidence. |
Management’s recurring strengths were translating aerospace-linked demand into SAO margin expansion and improving cash generation, while key challenges centered on interpreting quarter-to-quarter mix and managing smaller medical/defense volatility pockets.
Management repeatedly attributed SAO margin expansion to productivity gains, product mix optimization, and pricing actions. Each quarter raised the adjusted margin and operating income records, reinforcing durability through FY2026.
Order intake strengthened from Q1 into Q2 and continued through Q3 and Q4. Management linked the shift to OEM build-rate progress, structural customers moving off sidelines, and inventory tightening urgency.
FY2026 moved from a record but seasonally constrained Q1 into progressively stronger aerospace demand momentum, culminating in Q4 record profitability and continued cash generation.
SAO leverage with improving cash flow
The annual story evolved from early-year proof of execution and elevated pricing into a clearer aerospace ramp narrative, then into Q3–Q4 record margins and cash generation supported by brownfield investment.
Management opened FY2026 with record earnings and SAO margin expansion, attributing strength to productivity, mix optimization, and pricing actions. While aerospace demand looked stronger via accelerating orders, medical distribution softness and negative Q1 adjusted free cash flow highlighted near-term variability.
Read earnings transcriptQ2 reinforced accelerating aerospace activity and pricing tailwinds through additional LTAs, while management explained sequential net sales softness as holiday/operating-day effects. Defense order uncertainty and medical titanium weakness were treated as smaller, contained pockets not disrupting overall outlook.
Management guidance in FY2026 was directional and periodically updated; the transcripts include Q1 and Q2 raise/expectations that align with reported record quarters in later calls.
Not available
Revenue $733.7M; Gross margin 29.5%; EPS $2.43
Q1 commentary emphasized staying on/above record profitability expectations, while the actual financials show negative adjusted free cash flow from capex timing.
Not available
Revenue $728M; Gross margin 30.0%; EPS $2.09
Management described Q2 as setting up a strong second half with rising aerospace activity; actuals show flat sequential revenue and improved gross margin.
Topics that management and analysts returned to repeatedly during the year—especially aerospace ramp, pricing interpretation, and medical/defense volatility—could shape next-year expectations.
Structural demand is portrayed as lagging and then turning sharply, which can affect both volumes and mix.
Track management commentary on structural customers moving off sidelines and whether accelerate ordering becomes more consistent.
SAO margin expansion is the dominant profitability engine, and investors will watch whether productivity, mix, and pricing sustain the upward path.
Margin quality
Management framed SAO margin expansion as recurring, not a one-off, attributing it to productivity at key work centers, product mix optimization, and pricing actions. Q1 reached 32% with record operating income; Q4 pushed SAO adjusted operating margin to 37.8%.
Pricing power
Across the year, management emphasized its pricing framework—long-term agreements supporting surety of supply—and described ongoing repricing activity via multiple aerospace LTAs with significant price increases. Q2 and Q3 also addressed how “price per pound” can look uneven due to mix.
Cash & capital allocation
Quarterly reporting connected earnings to cash flow, with working-capital management highlighted—particularly inventory control—while brownfield expansion drove capex ramp. By Q3 and Q4, management increased free cash flow outlook as project deliveries and spending timing progressed.
Structural customers moved off sidelines; engine and structural order intake surged.
Positive Expedite/urgent delivery requests increased as inventories drew down. |
Positive Customers confirmed capacity-first mindset; structural orders stayed accelerating. |
| Track aerospace structural ordering cadence, expedite requests, and whether lead-time extensions persist. |
| SAO margin expansion compounding via productivity, mix, pricing | Positive SAO adjusted margin reached 32% with record operating income despite maintenance. | Positive SAO margin climbed to 33.1% as productivity and pricing actions continued. | Positive SAO margin set a new record at 35.6% alongside record operating income. | Positive SAO margin rose to 37.8%, exceeding management’s SAO operating income expectation. | Watch quarterly SAO adjusted margin trajectory and management commentary on mix effects. |
| Pricing stays elevated through LTAs and supply surety, not spot | Positive Five aerospace LTAs repriced; management argued no spot pricing lowers pressure. | Positive Three additional aerospace LTAs signed; management maintained pricing tailwind view. | Positive Pricing described as continuing tailwind; LTAs in negotiation supported economics. | Mixed Base price per pound discussion emphasized mix; margin still expanded. | Monitor LTA repricing cadence and how management explains price-per-pound changes via mix. |
| Brownfield capex timing and cash conversion resilience | Mixed Free cash flow was negative in Q1 as brownfield spending began accelerating. | Positive Adjusted free cash flow turned positive as capex ramped for brownfield project. | Positive Management increased free cash flow outlook while capex continued to ramp in Q3. | Positive FY cash generation came in ahead; brownfield completion timing reiterated for early FY28. | Track capex-to-free-cash-flow conversion and project spending timing into early FY28. |
| Medical titanium distribution softness with improving bookings | Negative Medical sales fell sequentially and year over year; distribution volatility persisted. | Negative PEP profitability pressured by titanium demand softness in distribution customers. | Mixed Medical sales remained down but bookings rose, supporting recovery expectations. | Positive Medical sales flipped up sequentially; orthopedics/dental/cardiology improved. | Monitor PEP operating income sensitivity to specific titanium distribution customers and medical bookings trend. |
| Defense ordering lumpy and impacted by budget/uncertainty then normalizing | Positive Defense demand described as increasing with urgent requests and program activity. | Negative Defense submarket orders down materially due to government shutdown uncertainty. | Mixed Defense activity increased but order pattern described as program-specific and lumpy. | Positive Defense demand stayed strong with urgent requests across multiple platforms. | Watch defense order intake commentary for normalization versus budget-driven lags. |
Management connected record earnings to stronger operating cash flow and adjusted free cash flow. Q1 and Q2 showed variability from capex timing, while later quarters improved outlook as working capital, especially inventory, was managed closely.
Buybacks continued each quarter as brownfield capex ramped. Management described maintaining a balanced approach—investing for growth while returning cash via dividend and repurchase programs.
Medical sales declined sequentially and year over year early in FY2026, with Q2 explicitly isolating pressure to certain titanium products for medical distribution customers. Management flagged forecasting uncertainty but suggested bookings improvement later.
Management noted defense submarket orders down materially in Q2 due to government shutdown and budget uncertainty, and later described defense as program-specific and inherently uneven. Investors had to treat defense as less linear than aerospace.
Across Q2 to Q4, management emphasized that selling price per pound can be influenced by mix of products shipped, which may create small sequential declines without signaling weaker pricing. Investors needed to focus on underlying pricing tailwind narrative.
Management described negative adjusted free cash flow in Q1 and discussed capex timing and progress-payment assumptions in later quarters. While liquidity remained strong, investors needed to watch cash flow timing alongside project milestones.
Scroll horizontally to see more columns.
| Quarter | Revenue | YoY revenue growth | Diluted EPS | Gross margin | Investor read |
|---|---|---|---|---|---|
| Q1Sep-25 | $733.7M | -2.9% | $2.43 | 29.5% | In Q1, management highlighted record operating income and SAO margin strength despite planned maintenance, while explaining medical volatility and expecting demand strength to build through the year. |
| Q2Dec-25 | $728M | -0.8% | $2.09 | 30.0% | Q2 reinforced the aerospace ramp and pricing tailwind, with structural and engine order intake accelerating, while management addressed defense shutdown uncertainty and clarified medical/titanium softness impacts. |
| Q3Mar-26 | $811.5M | 11.5% | $2.77 | 31.0% | By Q3, management characterized demand as accelerating across high-value markets and linked urgency to inventory drawdowns, while SAO margins hit new records and cash flow outlook improved. |
| Q4Jun-26 | $851M | 4.9% | $3.23 | 31.6% | In Q4, management sustained momentum with another record quarter, pushed SAO margins higher to 37.8%, and provided a conservative-but-higher FY27 and multi-year outlook supported by demand. |
In Q3, management described accelerating high-value demand and rising urgency across the aerospace supply chain, including requests for urgent deliveries. SAO delivered a new record adjusted operating margin, while cash flow improved as working capital and brownfield spending timing aligned more favorably.
Read earnings transcriptQ4 delivered another record operating income and SAO margin expansion, plus continued free cash flow and shareholder returns. Management emphasized mix-driven interpretation of base price-per-pound and issued FY27 operating income and cash outlook framed as achievable and potentially exceedable.
Read earnings transcriptNot available
Revenue $811.5M; Gross margin 31.0%; EPS $2.77
Q3 was framed as record execution and demand acceleration; actuals confirm large sequential revenue growth and continued margin expansion.
Not available
Revenue $851M; Gross margin 31.6%; EPS $3.23
While FY27 guidance was provided in Q4, FY2026 outcomes concluded with another record quarter; actuals show strongest gross margin and cash from operations.
Monitor SAO adjusted operating margin records and management explanations for mix-driven quarter-to-quarter variation.
Management links pricing power to long-term agreements and surety of supply; LTA renewals can influence realized pricing.
Watch how many significant aerospace LTAs come up for renewal and the qualitative magnitude of price increases described.
Brownfield capex is expected to keep ramping into early FY28, making cash timing and conversion key to capital allocation confidence.
Track adjusted free cash flow outlook and CapEx cadence commentary (ratable throughout the year).
Medical/PEP weakness was concentrated in specific titanium distribution customers, making segment results sensitive to demand normalization.
Monitor PEP operating income and medical bookings language about titanium distribution customers reaching bottom.
Dafinchi